252 related articles for article (PubMed ID: 7606712)
1. APC binds to the novel protein EB1.
Su LK; Burrell M; Hill DE; Gyuris J; Brent R; Wiltshire R; Trent J; Vogelstein B; Kinzler KW
Cancer Res; 1995 Jul; 55(14):2972-7. PubMed ID: 7606712
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human MAPRE genes and their proteins.
Su LK; Qi Y
Genomics; 2001 Jan; 71(2):142-9. PubMed ID: 11161807
[TBL] [Abstract][Full Text] [Related]
3. Regulation and function of the interaction between the APC tumour suppressor protein and EB1.
Askham JM; Moncur P; Markham AF; Morrison EE
Oncogene; 2000 Apr; 19(15):1950-8. PubMed ID: 10773885
[TBL] [Abstract][Full Text] [Related]
4. EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologue.
Nakagawa H; Koyama K; Murata Y; Morito M; Akiyama T; Nakamura Y
Oncogene; 2000 Jan; 19(2):210-6. PubMed ID: 10644998
[TBL] [Abstract][Full Text] [Related]
5. RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells.
Renner C; Pfitzenmeier JP; Gerlach K; Held G; Ohnesorge S; Sahin U; Bauer S; Pfreundschuh M
J Immunol; 1997 Aug; 159(3):1276-83. PubMed ID: 9233623
[TBL] [Abstract][Full Text] [Related]
6. EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle.
Morrison EE; Wardleworth BN; Askham JM; Markham AF; Meredith DM
Oncogene; 1998 Dec; 17(26):3471-7. PubMed ID: 10030671
[TBL] [Abstract][Full Text] [Related]
7. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene.
Rubinfeld B; Albert I; Porfiri E; Munemitsu S; Polakis P
Cancer Res; 1997 Oct; 57(20):4624-30. PubMed ID: 9377578
[TBL] [Abstract][Full Text] [Related]
8. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
[TBL] [Abstract][Full Text] [Related]
10. Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers.
Jaïs P; Sabourin JC; Bombled J; Rougier P; Lasser P; Duvillard P; Bénard J; Bressac-de Paillerets B
Br J Cancer; 1998 Nov; 78(10):1356-60. PubMed ID: 9823979
[TBL] [Abstract][Full Text] [Related]
11. The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain.
Erdmann KS; Kuhlmann J; Lessmann V; Herrmann L; Eulenburg V; Müller O; Heumann R
Oncogene; 2000 Aug; 19(34):3894-901. PubMed ID: 10951583
[TBL] [Abstract][Full Text] [Related]
12. Detection of protein truncating mutations in exons 1-14 of the APC gene using an in vivo fusion protein assay. Mutations in brief no. 214. Online.
Andreutti-Zaugg C; Couturier A; Chappuis P; Hutter P
Hum Mutat; 1999; 13(2):170-1. PubMed ID: 10094557
[TBL] [Abstract][Full Text] [Related]
13. APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.
Nakagawa H; Koyama K; Murata Y; Morito M; Akiyama T; Nakamura Y
Cancer Res; 2000 Jan; 60(1):101-5. PubMed ID: 10646860
[TBL] [Abstract][Full Text] [Related]
14. Association between wild type and mutant APC gene products.
Su LK; Johnson KA; Smith KJ; Hill DE; Vogelstein B; Kinzler KW
Cancer Res; 1993 Jun; 53(12):2728-31. PubMed ID: 8389242
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.
Bhattacharya G; Boman BM
Biochem Biophys Res Commun; 1995 Mar; 208(1):103-10. PubMed ID: 7887918
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition.
Wallis YL; Morton DG; McKeown CM; Macdonald F
J Med Genet; 1999 Jan; 36(1):14-20. PubMed ID: 9950360
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the EB1-APC interaction.
Honnappa S; John CM; Kostrewa D; Winkler FK; Steinmetz MO
EMBO J; 2005 Jan; 24(2):261-9. PubMed ID: 15616574
[TBL] [Abstract][Full Text] [Related]
18. The APC protein binds to A/T rich DNA sequences.
Deka J; Herter P; Sprenger-Haussels M; Koosch S; Franz D; Müller KM; Kuhnen C; Hoffmann I; Müller O
Oncogene; 1999 Oct; 18(41):5654-61. PubMed ID: 10523845
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
20. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
